BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 20124178)

  • 1. Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy.
    O'Brien MM; Donaldson SS; Balise RR; Whittemore AS; Link MP
    J Clin Oncol; 2010 Mar; 28(7):1232-9. PubMed ID: 20124178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose.
    Constine LS; Tarbell N; Hudson MM; Schwartz C; Fisher SG; Muhs AG; Basu SK; Kun LE; Ng A; Mauch P; Sandhu A; Culakova E; Lyman G; Mendenhall N
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):24-33. PubMed ID: 18722263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.
    Mauch PM; Kalish LA; Marcus KC; Coleman CN; Shulman LN; Krill E; Come S; Silver B; Canellos GP; Tarbell NJ
    Blood; 1996 May; 87(9):3625-32. PubMed ID: 8611686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin's Lymphoma Survivors.
    Abou-Antoun T; Mikhael R; Massoud M; Chahine G; Saad A
    Asian Pac J Cancer Prev; 2016; 17(2):749-54. PubMed ID: 26925674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
    J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina.
    Villanueva G; Sampor C; Moreno F; Alderete D; Moresco A; Pinto N; Szijan I; Schaiquevich P; Felice MS; Rose A; Zubizarreta P; Sgroi M; Fandiño A; Chantada G
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29710. PubMed ID: 35451226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
    Holmqvist AS; Chen Y; Berano Teh J; Sun C; Birch JM; van den Bos C; Diller LR; Dilley K; Ginsberg J; Martin LT; Nagarajan R; Nathan PC; Neglia JP; Terenziani M; Tishler D; Meadows AT; Robison LL; Oberlin O; Bhatia S
    Cancer; 2019 Apr; 125(8):1373-1383. PubMed ID: 30556153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary Malignancies Following Treatment for Hodgkin's Lymphoma in Childhood and Adolescence.
    Dörffel W; Riepenhausenl M; Lüders H; Brämswig J; Schellong G
    Dtsch Arztebl Int; 2015 May; 112(18):320-7, i. PubMed ID: 26037468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
    Kuttesch JF; Wexler LH; Marcus RB; Fairclough D; Weaver-McClure L; White M; Mao L; Delaney TF; Pratt CB; Horowitz ME; Kun LE
    J Clin Oncol; 1996 Oct; 14(10):2818-25. PubMed ID: 8874344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
    Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
    J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and clinical characteristics of second malignant neoplasms in children: a multicenter study of a polish pediatric leukemia/lymphoma group.
    Kowalczyk J; Nurzyńska-Flak J; Armata J; Bogusławska-Jaworska J; Rokicka-Milewska R; Sońta-Jakimczyk D; Balwierz W; Chybicka A; Kaczmarek-Kanold M; Wachowiak J; Matysiak M; Pawelec K
    Med Sci Monit; 2004 Mar; 10(3):CR117-22. PubMed ID: 14976453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
    De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced incidence of second solid tumors in survivors of childhood Hodgkin's lymphoma treated without radiation therapy.
    Barbaro PM; Johnston K; Dalla-Pozza L; Cohn RJ; Wang YA; Marshall GM; Ziegler DS
    Ann Oncol; 2011 Dec; 22(12):2569-2574. PubMed ID: 21393381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence.
    Green DM; Hyland A; Barcos MP; Reynolds JA; Lee RJ; Hall BC; Zevon MA
    J Clin Oncol; 2000 Apr; 18(7):1492-9. PubMed ID: 10735897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of second lung cancer in Hodgkin's lymphoma survivors: a meta-analysis.
    Ibrahim EM; Kazkaz GA; Abouelkhair KM; Al-Mansour MM; Al-Fayea TM; Al-Foheidi M; Bayer AM; Elmasri OA
    Lung; 2013 Feb; 191(1):117-34. PubMed ID: 23053567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
    Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
    J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
    Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
    Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid malignancies in survivors of Hodgkin lymphoma.
    Michaelson EM; Chen YH; Silver B; Tishler RB; Marcus KJ; Stevenson MA; Ng AK
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):636-41. PubMed ID: 24521679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of second breast cancer in female Hodgkin's lymphoma survivors: a meta-analysis.
    Ibrahim EM; Abouelkhair KM; Kazkaz GA; Elmasri OA; Al-Foheidi M
    BMC Cancer; 2012 May; 12():197. PubMed ID: 22639888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control study.
    Guérin S; Hawkins M; Shamsaldin A; Guibout C; Diallo I; Oberlin O; Brugières L; de Vathaire F
    J Clin Oncol; 2007 Jul; 25(19):2833-9. PubMed ID: 17602088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.